245 related articles for article (PubMed ID: 1887758)
21. Zinc therapy as the initial treatment for Wilson's disease.
Hoogenraad TU; Van Hattum J
Arch Neurol; 1988 Apr; 45(4):373-4. PubMed ID: 3355392
[No Abstract] [Full Text] [Related]
22. Low-dose zinc therapy for maintenance treatment of Wilson's disease.
Mayet IY
Clin Pharm; 1990 Dec; 9(12):951-3. PubMed ID: 2292179
[No Abstract] [Full Text] [Related]
23. Copper and zinc in the serum, urine, and hair of patients with Wilson's disease treated with penicillamine and zinc.
Dastych M; Procházková D; Pokorný A; Zdrazil L
Biol Trace Elem Res; 2010 Mar; 133(3):265-9. PubMed ID: 19562272
[TBL] [Abstract][Full Text] [Related]
24. Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report.
Haslam RH; Sass-Kortsak A; Stout W; Berg M
Dev Pharmacol Ther; 1980; 1(5):318-24. PubMed ID: 7438976
[TBL] [Abstract][Full Text] [Related]
25. [A study of trientine therapy in Wilson's disease with neurological symptoms].
Suda M; Kubota J; Yamaguchi Y; Fujioka Y; Saito Y; Aoki T
No To Hattatsu; 1993 Sep; 25(5):429-34. PubMed ID: 8398232
[TBL] [Abstract][Full Text] [Related]
26. Treatment of Wilson's disease with zinc. II. Validation of oral 64copper with copper balance.
Hill GM; Brewer GJ; Juni JE; Prasad AS; Dick RD
Am J Med Sci; 1986 Dec; 292(6):344-9. PubMed ID: 3799705
[TBL] [Abstract][Full Text] [Related]
27. Recognition, diagnosis, and management of Wilson's disease.
Brewer GJ
Proc Soc Exp Biol Med; 2000 Jan; 223(1):39-46. PubMed ID: 10632959
[TBL] [Abstract][Full Text] [Related]
28. The mechanisms of penicillamine, trientine, and zinc in the treatment of Wilson's disease.
Yarze JC
Am J Gastroenterol; 1995 Jun; 90(6):1026. PubMed ID: 7771405
[No Abstract] [Full Text] [Related]
29. [Pathogenesis and treatment of Wilson's disease].
Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
[TBL] [Abstract][Full Text] [Related]
30. Two and half years of oral zinc sulphate therapy in an adult patient with Wilson's disease.
Pasqualicchio M; Milanino R; Marrella M; Moretti U; Tomelleri G; Velo GP
Pharmacol Res; 1989; 21 Suppl 1():151-2. PubMed ID: 2633173
[No Abstract] [Full Text] [Related]
31. Clinical considerations for an effective medical therapy in Wilson's disease.
Weiss KH; Stremmel W
Ann N Y Acad Sci; 2014 May; 1315():81-5. PubMed ID: 24754532
[TBL] [Abstract][Full Text] [Related]
32. [Effect of oral ZnSO4 on urine copper and blood trace elements in 60 patients with Wilson's disease].
Yang RM
Zhonghua Yi Xue Za Zhi; 1986 Apr; 66(4):211-3, 254. PubMed ID: 3094875
[No Abstract] [Full Text] [Related]
33. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study.
Merle U; Schaefer M; Ferenci P; Stremmel W
Gut; 2007 Jan; 56(1):115-20. PubMed ID: 16709660
[TBL] [Abstract][Full Text] [Related]
34. [Wilson's disease].
Cramarossa L; D'Angelo D; D'Ascanio I; Ferri GB; Piane E
Recenti Prog Med; 1992 May; 83(5):255-61. PubMed ID: 1439104
[TBL] [Abstract][Full Text] [Related]
35. Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment.
Pfeiffenberger J; Lohse CM; Gotthardt D; Rupp C; Weiler M; Teufel U; Weiss KH; Gauss A
J Inherit Metab Dis; 2019 Mar; 42(2):371-380. PubMed ID: 30746719
[TBL] [Abstract][Full Text] [Related]
36. Treatment of Wilson's disease.
Deiss A
Ann Intern Med; 1983 Sep; 99(3):398-400. PubMed ID: 6614689
[No Abstract] [Full Text] [Related]
37. Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy.
Brewer GJ; Johnson VD; Dick RD; Hedera P; Fink JK; Kluin KJ
Hepatology; 2000 Feb; 31(2):364-70. PubMed ID: 10655259
[TBL] [Abstract][Full Text] [Related]
38. Wilson's disease: assessment of D-penicillamine treatment.
Van Caillie-Bertrand M; Degenhart HJ; Luijendijk I; Bouquet J; Sinaasappel M
Arch Dis Child; 1985 Jul; 60(7):652-5. PubMed ID: 4026361
[TBL] [Abstract][Full Text] [Related]
39. Trientine-induced neurological deterioration in a patient with Wilson's disease.
Kim B; Chung SJ; Shin HW
J Clin Neurosci; 2013 Apr; 20(4):606-8. PubMed ID: 23274038
[TBL] [Abstract][Full Text] [Related]
40. Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment.
Brewer GJ
CNS Drugs; 2005; 19(3):185-92. PubMed ID: 15740174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
